Herbal Drugs for Ophthalmic Use


S. no.

Ocular condition

Herbs reported to have beneficial effect

1

Dry eye

Natural polymer (gum) from tamarind seed, curcumin

2.

Glaucoma

Foeniculum vulgare, Lycium barbarum, Gingko biloba, Coleus forskohlii, Cannabis sativa, lutein, zeaxanthin, green tea, resveratrol, curcumin, safflower

3.

Cataract

Cineraria maritime, Momordica charantia, Eugenia jambolana, Tinospora cordifolia, T. foenum-graecum, Ocimum sanctum, P. marsupium, Murraya koenigii, Brassica juncea, Mucuna pruriens, Coleus forskohlii, Rosmarinus officinalis, Allium sativum, Ocimum sanctum, Gymnema sylvestre, Buddlejae flos, cinnamon, lutein, nobiletin, Withania somnifera, Aegle marmelos, Duchesnea chrysantha

4.

Anti-angiogenic

Gingko biloba, Vaccinium myrtillus, Stephania tetrandra, Magnolia officinalis, Dendrobium chrysotoxum, Boswellia serrata

5.

Uveitis

Curcumin, Scutellariae radix, Tripterygium wilfordii, Vaccinium myrtillus, Berberis aristata, Lonicera caerulea, fucoxanthin, lutein, Lycium





References



Agarwal R, Gupta SK, Agrawal SS, Srivastava S, Saxena R. Oculohypotensive effects of foeniculum vulgare in experimental models of glaucoma. Indian J Physiol Pharmacol. 2008;52(1):77–83.PubMed


Alekseev IB, Kochergin SA, Vorob’eva IV, Mikhaleva LG. On some pathogenic features of diabetic retinopathy in type II diabetes mellitus and the role of antioxidants and Ginkgo biloba. Vestn Oftalmol. 2013;129(3):89–93.PubMed


al-Sereiti MR, Abu-Amer KM, Sen P. Pharmacology of rosemary (Rosmarinus officinalis Linn.) and its therapeutic potentials. Indian Exp J Biol. 1999;37(2):124–30.


Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, Gøtzsche PC, Lang T, CONSORT Group (Consolidated Standards of Reporting Trials). The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001;134(8):663–94.PubMed


Anitha TS, Annadurai T, Thomas PA, Geraldine P. Prevention of selenite-induced cataractogenesis by an ethanolic extract of Cineraria maritima: an experimental evaluation of the traditional eye medication. Biol Trace Elem Res. 2011;143(1):425–36.PubMed


Anitha TS, Muralidharan AR, Annadurai T, Christdas Jesudasan AN, Thomas PA, Geraldine P. Putative free radical-scavenging activity of an extract of Cineraria maritima in preventing selenite-induced cataractogenesis in Wistar rat pups. Mol Vis. 2013;19:2551–60.PubMedPubMedCentral


Barabino S, Rolando M, Nardi M, Bonini S, Aragona P, Traverso CE. The effect of an artificial tear combining hyaluronic acid and tamarind seeds polysaccharide in patients with moderate dry eye syndrome: a new treatment for dry eye. Eur J Ophthalmol. 2014;24(2):173–8.PubMed


Bartlett H, Eperjesi F. An ideal ocular nutritional supplement? Ophthalmic Physiol Opt. 2004;24(4):339–49.PubMed


Bhardwaj A, Tanwar M. Effect of rasanjana madhu ashchyotana in netra abhishyanda (mucopurulent conjunctivitis). Ayu. 2011;32(3):365–9.PubMedPubMedCentral


Bhuyan KC, Bhuyan DK. Molecular mechanism of cataractogenesis: III. Toxic metabolites of oxygen as initiators of lipid peroxidation and cataract. Curr Eye Res. 1984;3(1):67–81.PubMed


Biswas NR, Gupta SK, Das GK, Kumar N, Mongre PK, Haldar D, Beri S. Evaluation of Ophthacare eye drops – a herbal formulation in the management of various ophthalmic disorders. Phytother Res. 2001;15(7):618–20.PubMed


Brubaker RF, Carlson KH, Kullerstrand LJ, McLaren JW. Topical forskolin (colforsin) and aqueous flow in humans. Arch Ophthalmol. 1987;105(5):637–41.PubMed


Burgalassi S, Panichi L, Chetoni P, Saettone MF, Boldrini E. Development of a simple dry eye model in the albino rabbit and evaluation of some tear substitutes. Ophthalmic Res. 1999;31(3):229–35.PubMed


Caprioli J, Sears M, Bausher L, et al. Forskolin lowers intraocular pressure by reducing aqueous inflow. Invest Ophthalmol Vis Sci. 1984;25(3):268–77.PubMed


Chang RC, So KF. Use of anti-aging herbal medicine, Lycium barbarum, against aging-associated diseases. What do we know so far? Cell Mol Neurobiol. 2008;28(5):643–52.PubMed


Chen M, Hu DN, Pan Z, Lu CW, Xue CY, Aass I. Curcumin protects against hyperosmoticity-induced IL-1beta elevation in human corneal epithelial cell via MAPK pathways. Exp Eye Res. 2010;90(3):437–43.PubMed


Chien FY, Wang RF, Mittag TW, Podos SM. Effect of WIN 55212–2, a cannabinoid receptor agonist, on aqueous humor dynamics in monkeys. Arch Ophthalmol. 2003;121(1):87–90.PubMed


Das GK, Pandey RM, Biswas NR. Comparative double masked randomised placebo controlled clinical trial of a herbal eye drop preparation in trachoma and conjunctivitis. J Indian Med Assoc. 1995;93(10): 383–4.


Deng Y, Wang M, Duan J. The modality of huoxue-huayu in treatment of retinal vein occlusion. Yan Ke Xue Bao. 1995;11(1):57–60.PubMed


Dhiman KS, Sharma G, Singh S. A clinical study to assess the efficacy of Triyushnadi Anjana in Kaphaja Abhishyanda with special reference to vernal keratoconjunctivitis. Ayu. 2010;31(4):466–72.PubMedPubMedCentral


Dhiman KS, Ahuja DK, Sharma SK. Clinical efficacy of Ayurvedic management in computer vision syndrome: a pilot study. Ayu. 2012;33(3):391–5.PubMedPubMedCentral


Doly M, Droy-Lefaix MT, Bonhomme B, Braquet P. Effect of Ginkgo biloba extract on the electrophysiology of the isolated retina from a diabetic rat. Presse Med. 1986;15(31):1480–3.PubMed


Fischer KM, Ward DA, Hendrix DV. Effects of a topically applied 2% delta-9-tetrahydrocannabinol ophthalmic solution on intraocular pressure and aqueous humor flow rate in clinically normal dogs. Am J Vet Res. 2013;74(2):275–80.PubMed


Fønnebø V, Grimsgaard S, Walach H, Ritenbaugh C, Norheim AJ, MacPherson H, Lewith G, Launsø L, Koithan M, Falkenberg T, Boon H, Aickin M. Researching complementary and alternative treatments – the gatekeepers are not at home. BMC Med Res Methodol. 2007;7:7.PubMedPubMedCentral


Fraunfelder FW. Ocular side effects from herbal medicines and nutritional supplements. Am J Ophthalmol. 2004;138(4):639–47.PubMed


Fraunfelder FW. Ocular side effects associated with dietary supplements and herbal medicines. Drugs Today (Barc). 2005;41(8):537–45.


Gagnier JJ, Boon H, Rochon P, Moher D, Barnes J, Bombardier C, CONSORT Group. Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement. Ann Intern Med. 2006;144(5):364–7.PubMed


Gopinathan G, Dhiman KS, Manjusha R. A clinical study to evaluate the efficacy of Trataka Yoga Kriya and eye exercises (non-pharmocological methods) in the management of Timira (Ammetropia and Presbyopia). Ayu. 2012;33(4):543–6.PubMedPubMedCentral


Gupta SK, Srivastava S, Trivedi D, Joshi S, Halder N. Ocimum sanctum modulates selenite-induced cataractogenic changes and prevents rat lens opacification. Curr Eye Res. 2005;30(7):583–91.PubMed


Gupta SK, Niranjan DG, Agrawal SS, Srivastava S, Saxena R. Recent advances in pharmacotherapy of glaucoma. Indian J Pharmacol. 2008; 40(5):197–208.


Gupta DP, Rajagopala M, Dhiman KS. A clinical study on Akshitarpana and combination of Akshitarpana with Nasya therapy in Timira with special reference to myopia. Ayu. 2010;31(4):473–7.PubMedPubMedCentral


Gupta SK, Kalaiselvan V, Srivastava S, Saxena R, Agrawal SS. Trigonella foenum-graecum (Fenugreek) protects against selenite-induced oxidative stress in experimental cataractogenesis. Biol Trace Elem Res. 2010;136(3):258–68.PubMed


Halder N, Joshi S, Gupta SK. Lens aldose reductase inhibiting potential of some indigenous plants. J Ethnopharmacol. 2003;86(1):113–6.PubMed
< div class='tao-gold-member'>

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 22, 2016 | Posted by in PHARMACY | Comments Off on Herbal Drugs for Ophthalmic Use

Full access? Get Clinical Tree

Get Clinical Tree app for offline access